Abbott - Rethinking ES-SCLC: Scientific evidence, biomarkers and the path forward

Name: Abbott - Rethinking ES-SCLC: Scientific evidence, biomarkers and the path forward
Start: 2026-12-06T12:30
End: 2026-12-06T14:00
Location: Suntec Convention Centre

ESMO Asia 2026 · 6 December 2026 · 12:30–14:00 · Hall 407

Abbott - Rethinking ES-SCLC: Scientific evidence, biomarkers and the path forward was a session at ESMO Asia 2026 on 6 December 2026 in Singapore, with 3 speakers on record.

Speakers

Lucksamon Thamlikitkul — Panelist Mahidol University - Faculty of Medicine
Jonathan W. Riess — Panelist UC Davis Comprehensive Cancer Center
Daniel Shao Weng Tan — Chair NCCS - National Cancer Centre Singapore